25I-NB34MD


25I-NB34MD is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a potent partial agonist for the human 5-HT2A receptor, and presumably has similar properties to 2C-I. It has a binding affinity of 0.67nM at the human 5-HT2A receptor, making it several times weaker than its positional isomer 25I-NBMD and a similar potency to 25I-NBF.

Society and culture

Legal status

Hungary

Illegal.

Japan

Illegal.

Sweden

added 25I-NB34MD to Narcotic Drugs Punishments Act under Swedish schedule I as of June 9, 2015, published by Medical [Products Agency (Sweden)|Medical Products Agency (MPA)] in regulation LVFS 2015:4 listed as 25I-NB34MD, and 2--N-etanamin.

United Kingdom